Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CURI +31.3%, HLIT +23.8%, OMER +16.3%, ENS +13.5% (also increases dividend), WWW +13.5%, BIRK +12.1%, AVAH +10.8%, AZ +9%, FOSL +8.7%, GO +8.3%, PESI +6.5%, EQPT +6.4%, JACK +6.1%, NOA +6%, LAC +5.2%, TBBB +4.8%, LGN +4.8%, PSFE +4.7%, MWH +4.7%, AEBI +4.4%, AIT +3.2%, POET +3.2%, ALH +3%, FRMI +2.9%, GWRS +2.8%, BLSH +2.7%, ARCO +2.2%, YSWY +2%, ALLO +1.9% (also files for $500 mln mixed shelf offering), BSP +1.6%, PBLS +1.6%, WHK +1.4% (also $111.8 mln in acquisitions; initiates quarterly dividend), PSUS +1.4%, CAE +1.1%, SSYS +1.1%
Other news:
- ARX +45.3% (to be acquired by Thoma Bravo for $20.25/share in cash)
- CGEM +6.9% (zipalertinib plus chemotherapy meets Phase 3 PFS endpoint in first-line EGFR exon 20 NSCLC)
- AMBP +6.1% (files an amendment to Schedule 13D with the U.S. Securities and Exchange Commission regarding Ardagh Metal Packaging S.A.)
- PHAR +4.2% (launches Joenja in Japan for APDS patients aged 4 and older)
- ISSC +3.3% (to supply avionics and main display system for eVTOL program)
- WYFI +3% (partners with Krambu for 100MW of GPU data center capacity starting in 2027)
- FRMI +2.3% (names new CEO)
- WGO +1.9% (increases dividend)
- FUL +1.7% (confirms receipt of cash proposal for Building Adhesive Solutions unit)
- PHM +1.4% (master repurchase agreement with TFC)
- EQR +1.4% (co and AVB win shareholder approval for merger)
- AB +1.3% (reports July AUM)
- ECO +1.2% (increases quarterly dividend 162.5% to $5.25/share from $2.00/share)
- GNK +1% (takes delivery of 2019-built Capesize vessel)
- IBM +1% (partners with OpenAI on enterprise AI deployment, launches dedicated OpenAI practice)
- SGMT +1% (gets FDA study may proceed letter for Phase 3 denifanstat acne trial)